Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer
Recruiting now · Not applicable
Conditions studied: Endometrial Cancer, Endometrial Neoplasms, Obesity, Morbid, Gynecologic Cancer, Gynecologic Disease
In brief
Data across literature suggest that robotic surgery may offer benefit specifically in patient with morbid obesity with endometrial cancer, but to date no randomized trials have been conducted to confirm these observations. This randomized controlled multicentric trial aims to evaluate the most appropriate minimally invasive surgical approach in morbidly obese (BMI \>= 30) patients with endometrial carcinoma.
Key facts
- Study ID
- NCT05974995
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- People needed
- 566
- Starts
- 2023-09-01
- Expected to finish
- 2029-09-01
- Last updated by the study team
- 2024-10-03
Who can join
Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- BMI >=30
- Age > 18
- Histologically confirmed endometrioid endometrial cancer
- Clinical early stage (stage I)
- No contraindication for minimally invasive surgery
- ASA<4
- Written informed consent.
You may not qualify if…
- High probability of laparotomy related to uterine volume (US estimated weight >250 g)
- Concomitant pelvic disease, or anatomical characteristics of the patient
- (Use of uterine manipulator)
- Age >75 years
Where it is running
- Policlinico Gemelli IRCCS — Rome, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.